Scientific Reports (Feb 2021)

rs1944919 on chromosome 11q23.1 and its effector genes COLCA1/COLCA2 confer susceptibility to primary biliary cholangitis

  • Yuki Hitomi,
  • Yoshihiro Aiba,
  • Yosuke Kawai,
  • Kaname Kojima,
  • Kazuko Ueno,
  • Nao Nishida,
  • Minae Kawashima,
  • Olivier Gervais,
  • Seik-Soon Khor,
  • Masao Nagasaki,
  • Katsushi Tokunaga,
  • Minoru Nakamura,
  • Makoto Tsuiji

DOI
https://doi.org/10.1038/s41598-021-84042-x
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Primary biliary cholangitis (PBC) is a chronic, progressive cholestatic liver disease in which intrahepatic bile ducts are destroyed by an autoimmune reaction. Our previous genome-wide association study (GWAS) identified chromosome 11q23.1 as a susceptibility gene locus for PBC in the Japanese population. Here, high-density association mapping based on single nucleotide polymorphism (SNP) imputation and in silico/in vitro functional analyses identified rs1944919 as the primary functional variant. Expression-quantitative trait loci analyses showed that the PBC susceptibility allele of rs1944919 was significantly associated with increased COLCA1/COLCA2 expression levels. Additionally, the effects of rs1944919 on COLCA1/COLCA2 expression levels were confirmed using genotype knock-in versions of cell lines constructed using the CRISPR/Cas9 system and differed between rs1944919-G/G clones and -T/T clones. To our knowledge, this is the first study to demonstrate the contribution of COLCA1/COLCA2 to PBC susceptibility.